Actavia Life Sciences, Inc.
RASP
$0.004
-$0.0285-87.69%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -95.50K | -147.60K | -58.30K | -105.20K | -4.13M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 15.80K | 14.90K | 3.90K | 0.00 | 164.10K |
| Total Other Non-Cash Items | 8.00K | 8.00K | 5.60K | 4.80K | 3.86M |
| Change in Net Operating Assets | 35.90K | 77.50K | 55.50K | 110.30K | 83.90K |
| Cash from Operations | -35.80K | -47.30K | 6.70K | 10.00K | -23.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 18.00K | -- | 80.00K | 0.00 | 0.00 |
| Total Debt Repaid | 0.00 | -8.50K | -14.10K | -9.70K | -21.60K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18.00K | -8.50K | 65.90K | -9.70K | -21.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.80K | -55.80K | 72.50K | 300.00 | -45.30K |
